세계 안과용 레이저 시장 규모는 2023년 15억 1,000만 달러, 2031년 23억 8,000만 달러에 달할 것으로 예상되며, 2024-2031년 예측 기간 동안 연평균 5.86% 성장할 것으로 예상됩니다. 세계 안과용 레이저 시장은 안과 기기 시장에서 가장 빠르게 성장하는 시장입니다. 세계 안과용 레이저 시장은 안과 질환의 유병률 증가, 노령 인구 증가, 레이저 장치 기술 발전 등의 요인에 의해 주도되고 있습니다. 안과 환자 수는 장시간의 스크린 사용, 라이프스타일 변화, 영양 부족, 만성 질환 등의 요인으로 인해 전 세계적으로 증가하고 있습니다. 이러한 요인들은 안과용 레이저 장치에 대한 엄청난 수요를 촉진하고 있습니다.
노령 인구의 증가는 시력 장애를 필요로 하는 사람들의 수를 증가시킬 것으로 예상됩니다. 또한, 안과 질환이 만성 질환의 주요 동반 질환이라는 점에서 당뇨병, 고혈압과 같은 만성 질환의 유병률 증가는 안과 질환에 대한 수요를 증가시킬 것으로 예상됩니다. 디자인 최적화, 기능 개선, 부작용 감소 등 다양한 기술 발전이 안과용 레이저 기기 수요 확대에 기여하고 있습니다. 정부의 우호적인 정책은 의료 인프라와 의료기기 공급을 강화하여 시장을 촉진하고 있습니다. 레이저 안과 치료는 기존 치료법에 비해 통증이 적고, 효과가 높으며, 입원 기간이 짧고, 절개할 필요가 없는 등 여러 가지 장점이 있어 백내장, AMD, 녹내장 등 안과 질환의 관리에 선호되고 있습니다. 그러나 레이저 치료의 높은 비용과 숙련된 전문가의 부족은 예측 기간 동안 시장 성장을 저해할 수 있습니다.
2023년 4월, Johnson & Johnson Vision은 새로운 ELITA Femtosecond Laser의 FDA 510(k) 승인을 획득했다고 발표했습니다. ELITA 펨토세컨드 레이저 플랩은 펄스당 낮은 에너지, 초고속 레이저 반복 속도, 작은 스팟 크기로 외과 의사의 속도와 정확성을 향상시킵니다.
불건강한 생활습관, 영양 부족, 장시간의 스크린 사용으로 인한 안과 질환의 유병률 증가는 안과용 레이저 시장의 수요를 촉진하고 있습니다. 가장 흔한 안과 질환으로는 근시, 굴절 이상, 백내장, 당뇨망막병증, 녹내장, 노화성 황반변성 등이 있습니다. 이러한 질환에 대해 레이저 치료가 효과적임이 입증되었고, 수술 후 관리 기간이 짧기 때문에 대부분의 외과의사들은 레이저 치료를 권장하고 있습니다.
예를 들어, WHO가 2023년 8월에 발표한 팩트 시트에 따르면, 전 세계적으로 약 22억 명이 근거리 또는 원거리 시력 장애를 앓고 있으며, 그 중 약 10억 명이 원거리 시력 장애, 10억 명이 백내장으로 인한 실명, 8,840만 명이 굴절 이상, 800만 명이 황반변성, 770만 명 녹내장, 390만 명이 당뇨병성 망막증을 앓고 있습니다. 근거리 시력 장애의 주요 원인은 노안이며, 환자 수는 약 8억 2,600만 명에 달합니다.
안과 질환에 취약한 노년층 인구의 증가는 안과용 레이저 치료에 대한 수요를 크게 촉진하고 있습니다. 나이가 들어감에 따라 노화 관련 요인으로 인한 안과 질환의 가능성이 높아집니다. 일본과 같은 국가는 노인 인구가 많기 때문에 시장 점유율의 대부분을 차지하고 있으며, WHO 데이터에 따르면 2030년까지 전 세계 인구 6명 중 1명이 60세 이상이 될 것으로 예상되며, 총 14억 명이 될 것으로 예상되며, WHO는 2020년 노령인구를 10억 명으로 추정하고 있습니다. 2020-2050년 사이 80세 이상 인구는 4배 증가하여 약 4억 2,600만 명에 달할 것으로 예상되며, National Health and Aging Trends Study에 따르면, 미국에서는 71세 이상 성인의 27.8%가 시각장애를 겪고 있습니다.
이 보고서는 세계 안과용 레이저 시장에 대해 조사 분석했으며, 시장 규모와 예측, 시장 역학, 주요 기업 현황과 전망 등을 제공합니다.
Global ophthalmic lasers market size was valued at USD 1.51 billion in 2023, and is expected to reach USD 2.38 billion in 2031, with a CAGR of 5.86% for the forecast period between 2024 and 2031F. The global ophthalmic lasers market is a fast-growing market within the ophthalmic devices market. The global ophthalmic lasers market is driven by factors such as the growing prevalence of ophthalmic disorders, rising geriatric population, and technological advancements in laser devices. The number of ophthalmic patients is increasing globally owing to factors such as longer screen time, lifestyle changes, lack of nutrition, and chronic diseases. These factors are driving huge demand for ophthalmic laser devices.
Growth in geriatric population is expected to increase the number of people who require vision impairment. Additionally, the growing prevalence of chronic diseases, such as diabetes and hypertension, are expected to draw demand for laser devices as ophthalmic disorders are prominent comorbidities with chronic diseases. Technological advancements like design optimization, functionality improvement, reducing side effects, and many others are favoring the growth in demand for ophthalmic laser devices. Favorable government policies strengthen the healthcare infrastructure and medical device availability, promoting the market. Laser ophthalmic treatments have several benefits over conventional treatment methods such as less pain, high effectivity, shorter hospital stay, and no need for incision, thus preferred over conventional methods for managing ophthalmic diseases like cataracts, AMD, and glaucoma. However, factors like the high cost of laser therapies and the lack of skilled professionals may hinder market growth during the forecast period.
In April 2023, Johnson & Johnson Vision announced that it had received FDA 510(k) clearance for its new ELITA Femtosecond Laser FDA 510(k) clearance to create LASIK flaps. Johnson & Johnson Vision has been a leader in the ophthalmic devices industry for the last two decades with a promising product portfolio. The ELITA Femtosecond laser flap offers low energy per pulse, with ultra-fast laser repetition rate and small spot size, facilitating the surgeon's speed and accuracy.
The growing prevalence of ophthalmic disorders due to unhealthy lifestyles, nutritional deficiency, and longer screen time is driving the demand in the ophthalmic lasers market. Most common ophthalmic disorders include myopia, refractive errors, cataracts, diabetic retinopathy, glaucoma, and age-related macular degeneration. Most surgeons recommend laser treatments for such diseases as they are proven effective and require a shorter post-operative care period.
For instance, according to a factsheet published by WHO in August 2023, around 2.2 billion individuals are suffering from near or distance vision impairment across the globe, out of which approx. 1 billion people suffer from distance vision impairment, 1 billion from blindness with cataracts, 88.4 million from refractive error, 8 million from age-related macular degeneration, 7.7 million from glaucoma, and 3.9 million from diabetic retinopathy. The major defect causing near vision impairment is presbyopia with a number of around 826 million patients.
The growing geriatric population that is highly prone to ophthalmic disorders is significantly driving the demand for ophthalmic laser treatments. With age, the chances of ophthalmic diseases increase due to age-associated factors. Countries such as Japan have a very high number of old age individuals and thus are contributing a major chunk of value share to the market. As per WHO data, by 2030, 1 out of 6 individuals worldwide will be above the age of 60 years, which is expected to be 1.4 billion population in total. WHO estimated 1 billion geriatric population in 2020. The number is expected to double (to 2.1 billion) by 2050. It is anticipated that between 2020 and 2050, the number of people 80 years of age or older will quadruple, reaching approx. 426 million counts. According to the National Health and Aging Trends Study, 27.8% of United States adults 71 years and older had visual impairments.
The femtosecond laser segment in global ophthalmic lasers is expected to dominate during the forecast period. Femtosecond laser is highly effective for the treatment of cataracts and refractive errors in the eye and, thus, is very commonly used. The growing prevalence of cataracts and technological advancements in femtosecond laser devices are some reasons for their dominance. Market players are investing in femtosecond laser technology to add cutting-edge products to their portfolio. For instance, in February 2023, Fluence announced the launch of Jasper Micro, a new addition to its Jasper range of femtosecond lasers. Jasper Micro is an air-cooled and very compact device with widespread applications like LASIK, PRK, and DNA transfection eye surgeries.
Asia-Pacific is home to developing countries, like India and China, which have a significantly high burden of ophthalmic diseases. The rising geriatric population with a higher affinity to ophthalmic diseases is driving the demand for ophthalmic lasers. The growing investment in the healthcare sector is helping expand the associated markets. Increasing investors' attention towards the region is opening opportunities for market expansion. Demand for efficient ophthalmic equipment in Asia-Pacific is increasing owing to rapidly evolving technologies. Heavy emphasis on preventive care and early intervention for ophthalmic disorders fuels the demand for ophthalmic lasers during the assessment period.
The healthcare infrastructure is developing and getting strengthened in nations across the globe and multiple attempts are being made to reduce the burden of ophthalmic diseases, for example, the integrated people-centered eye care (IPEC) initiative by WHO. Noval technology penetration in ophthalmic laser devices such as developments in femtosecond laser technology, the use of wavefront technology, and the use of adaptive optics are anticipated to strengthen the market dynamics in future years. These advances are anticipated to help surgeons perform more intricate and precise surgeries in the future through highly evolved lasers.
Market players are expanding their product offerings and giving their customers access to a wide range of cutting-edge and novel products using a variety of strategies. To gain market share, companies are expanding their range of products being offered. Industry participants use various growth methods, including collaborations, mergers and acquisitions, product launches, and development of new products, to bolster their positions in the market.
In December 2023, Carl Zeiss Meditec AG announced the agreement to acquire 100% shares of the Dutch Ophthalmic Research Center (DORC) from the France-based investment firm Eurazeo. The deal is valued at EUR 985 million and is expected to close in the first half of 2024. DORC's offer robust portfolio includes devices, disposables, and liquids for ophthalmic surgeries, with prime focus on its dual-function Eva Nexustm platform.
All segments will be provided for all regions and countries covered:
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.